Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

被引：0
|
作者：
Bommakanti, Nikhil
Young, Benjamin K.
Sisk, Robert A.
Berrocal, Audina M.
Duncan, Jacque L.
Bakall, Benjamin
Mathias, Marc T.
Ahmed, Ishrat
Chorfi, Sarah
Comander, Jason
Nagiel, Aaron
Besirli, Cagri G.
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 47 条
  • [1] Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration
    Bommakanti, Nikhil
    Young, Benjamin K.
    Sisk, Robert A.
    Berrocal, Audina M.
    Duncan, Jacque L.
    Bakall, Benjamin
    Mathias, Marc T.
    Ahmed, Ishrat
    Chorfi, Sarah
    Comander, Jason
    Nagiel, Aaron
    Besirli, Cagri G.
    OPHTHALMOLOGY RETINA, 2024, 8 (01): : 42 - 48
  • [2] Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis
    Gange, William S.
    Sisk, Robert A.
    Besirli, Cagri G.
    Lee, Thomas C.
    Havunjian, Margaret
    Schwartz, Hillary
    Borchert, Mark
    Sengillo, Jesse D.
    Mendoza, Carlos
    Berrocal, Audina M.
    Nagiel, Aaron
    OPHTHALMOLOGY RETINA, 2022, 6 (01): : 58 - 64
  • [3] Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis
    Gange, William S.
    Sisk, Robert A.
    Besirli, Cagri G.
    Lee, Thomas C.
    Havunjian, Margaret
    Schwartz, Hillary
    Borchert, Mark
    Sengillo, Jesse D.
    Mendoza, Carlos
    Berrocal, Audina M.
    Nagiel, Aaron
    OPHTHALMOLOGY, 2022, 129 (02) : 125 - 125
  • [4] Perifoveal Chorioretinal Atrophy Following Subretinal Injection of Voretigene Neparvovec-rzyl for RPE65-mediated Leber Congenital Amaurosis
    Gange, William S.
    Sisk, Robert A.
    Besirli, Cagri G.
    Lee, Thomas C.
    Borchert, Mark
    Sengillo, Jesse
    Mendoza, Carlos
    Berrocal, Audina M.
    Nagiel, Aaron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [5] Subretinal Deposits in Young Patients Treated with Voretigene Neparvovec-rzyl for RPE65-mediated Retinal Dystrophy
    不详
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [6] Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy
    Lopez, Jennifer
    Borchert, Mark
    Lee, Thomas C.
    Nagiel, Aaron
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (03) : 299 - 301
  • [7] Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease
    Johnson, Scott
    Buessing, Marric
    O'Connell, Thomas
    Pitluck, Sarah
    Ciulla, Thomas A.
    JAMA OPHTHALMOLOGY, 2019, 137 (10) : 1115 - 1123
  • [8] Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development
    Ciulla, Thomas A.
    Hussain, Rehan M.
    Berrocal, Audina M.
    Nagiel, Aaron
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 565 - 578
  • [9] Classification and growth rate of retinal atrophy after voretigene neparvovecrzyl for RPE65-mediated retinal dystrophy
    Bommakanti, Nikhil
    Young, Benjamin
    Sisk, Robert
    Berrocal, Audina M.
    Duncan, Jacque L.
    Bakall, Benjamin
    Mathias, Marc
    Nagiel, Aaron
    Besirli, Cagri G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [10] Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration
    Kuenzel, Sandrine
    Sassmannshausen, Marlene
    Sassen, Josua
    Preising, Markus
    Holz, Frank
    Lorenz, Birgit
    Herrmann, Philipp
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345